ICAM1 and gastric cancer: In a xenograft animal model of gastric cancer, monotherapy with either ICAM-1-specific CAR-T cells or paclitaxel, a cytotoxic drug commonly used in gastric cancer, reduced the tumor burden but did not induce long-term survival of tumor-bearing mice [100].